The effects of Valette on skin and hair: a post-marketing surveillance study

Observational OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-14 ⓘ

This post-marketing surveillance study found that Valette, an oral contraceptive, improved moderate to severe greasy hair and skin disorders in over 10,000 women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effects of Valette--an oral contraceptive containing ethinyloestradiol 0.03 mg and the antiandrogenic progestogen dienogest 2.0 mg--on the skin and hair were surveyed over 63,474 cycles in 10,718 women in routine gynaecological practice. Improvements were greatest in women with severe or moderate androgen-related symptoms. After six cycles, < 1% of women had severely greasy hair and 6% had moderate greasiness, compared with 11% and 27% at baseline; fewer hair washes were needed per week. The incidence of severe and moderately greasy skin disorders fell from 16% to < 1%, and from 39% to 7.5%, respectively. Self-assessments indicated less greasy hair and improved greasy skin disorders in 70% and 81% of women, respectively. The overall effect of Valette on the skin and hair was rated very good or good by 87.5% of women. These results confirm previous observations of a beneficial effect of Valette on androgen-related skin and hair conditions.

My notes (saved in your browser only)

MeSH descriptors

Contraceptives, Oral, Combined Estradiol Congeners Ethinyl Estradiol Hair Nandrolone Skin Adolescent Adult Contraceptives, Oral, Combined Contraceptives, Oral, Combined Estradiol Congeners Ethinyl Estradiol Female Germany Hair Humans Nandrolone Nandrolone Patient Compliance Product Surveillance, Postmarketing

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (4)

Cited by (4)

Source provenance

openalex
last seen: 2026-05-10T11:05:30.529663+00:00
pubmed
last seen: 2026-10-08T20:59:21.759586+00:00
License: CC0 · commercial use OK